Valeo Financial Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,014
| Closed | -$201K | – | 720 |
|
|
2024
Q3 | $201K | Sell |
3,014
-53
| -2% | -$3.54K | 0.01% | 652 |
|
|
2024
Q2 | $364K | Sell |
3,067
-239
| -7% | -$28.4K | 0.01% | 468 |
|
|
2024
Q1 | $360K | Sell |
3,306
-1,251
| -27% | -$136K | 0.01% | 453 |
|
|
2023
Q4 | $453K | Sell |
4,557
-116
| -2% | -$11.5K | 0.02% | 391 |
|
|
2023
Q3 | $483K | Buy |
4,673
+854
| +22% | +$88.2K | 0.02% | 341 |
|
|
2023
Q2 | $464K | Buy |
3,819
+324
| +9% | +$39.4K | 0.02% | 340 |
|
|
2023
Q1 | $537K | Sell |
3,495
-118
| -3% | -$18.1K | 0.03% | 320 |
|
|
2022
Q4 | $649K | Buy |
3,613
+1,036
| +40% | +$186K | 0.04% | 238 |
|
|
2022
Q3 | $305K | Sell |
2,577
-155
| -6% | -$18.3K | 0.02% | 333 |
|
|
2022
Q2 | $390K | Buy |
2,732
+674
| +33% | +$96.2K | 0.02% | 290 |
|
|
2022
Q1 | $355K | Buy |
2,058
+621
| +43% | +$107K | 0.02% | 387 |
|
|
2021
Q4 | $365K | Buy |
1,437
+110
| +8% | +$27.9K | 0.02% | 361 |
|
|
2021
Q3 | $511K | Buy |
1,327
+51
| +4% | +$19.6K | 0.03% | 284 |
|
|
2021
Q2 | $300K | Sell |
1,276
-450
| -26% | -$106K | 0.02% | 336 |
|
|
2021
Q1 | $226K | Buy |
1,726
+481
| +39% | +$63K | 0.01% | 406 |
|
|
2020
Q4 | $130K | Sell |
1,245
-916
| -42% | -$95.6K | 0.01% | 497 |
|
|
2020
Q3 | $153K | Sell |
2,161
-54
| -2% | -$3.82K | 0.01% | 365 |
|
|
2020
Q2 | $142K | Buy |
2,215
+415
| +23% | +$26.6K | 0.01% | 386 |
|
|
2020
Q1 | $57K | Buy |
1,800
+1,100
| +157% | +$34.8K | 0.01% | 541 |
|
|
2019
Q4 | $14K | Hold |
700
| – | – | ﹤0.01% | 994 |
|
|
2019
Q3 | $11K | Hold |
700
| – | – | ﹤0.01% | 997 |
|
|
2019
Q2 | $10K | Hold |
700
| – | – | ﹤0.01% | 1021 |
|
|
2019
Q1 | $14K | Buy |
+700
| New | +$14K | ﹤0.01% | 864 |
|